These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28056866)

  • 1. Case report: whole exome sequencing of primary cardiac angiosarcoma highlights potential for targeted therapies.
    Zhrebker L; Cherni I; Gross LM; Hinshelwood MM; Reese M; Aldrich J; Guileyardo JM; Roberts WC; Craig D; Von Hoff DD; Mennel RG; Carpten JD
    BMC Cancer; 2017 Jan; 17(1):17. PubMed ID: 28056866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recurrent activating PLCG1 mutation in cardiac angiosarcomas increases apoptosis resistance and invasiveness of endothelial cells.
    Kunze K; Spieker T; Gamerdinger U; Nau K; Berger J; Dreyer T; Sindermann JR; Hoffmeier A; Gattenlöhner S; Bräuninger A
    Cancer Res; 2014 Nov; 74(21):6173-83. PubMed ID: 25252913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.
    Huang SC; Zhang L; Sung YS; Chen CL; Kao YC; Agaram NP; Singer S; Tap WD; D'Angelo S; Antonescu CR
    Am J Surg Pathol; 2016 May; 40(5):645-55. PubMed ID: 26735859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research.
    Painter CA; Jain E; Tomson BN; Dunphy M; Stoddard RE; Thomas BS; Damon AL; Shah S; Kim D; Gómez Tejeda Zañudo J; Hornick JL; Chen YL; Merriam P; Raut CP; Demetri GD; Van Tine BA; Lander ES; Golub TR; Wagle N
    Nat Med; 2020 Feb; 26(2):181-187. PubMed ID: 32042194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. POT1 and Damage Response Malfunction Trigger Acquisition of Somatic Activating Mutations in the VEGF Pathway in Cardiac Angiosarcomas.
    Calvete O; Garcia-Pavia P; Domínguez F; Mosteiro L; Pérez-Cabornero L; Cantalapiedra D; Zorio E; Ramón Y Cajal T; Crespo-Leiro MG; Teulé Á; Lázaro C; Morente MM; Urioste M; Benitez J
    J Am Heart Assoc; 2019 Sep; 8(18):e012875. PubMed ID: 31510873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of consistent BRAF/HRAS gene mutation and MYC amplification radiation-induced abdominal wall angiosarcoma with low-dose apatinib: a case report.
    Guan J; Luo Z; Xiao Z; Xie Y; Lin L
    BMC Cancer; 2019 Dec; 19(1):1188. PubMed ID: 31805975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Analysis of Renal/Adrenal Angiosarcomas Reveals High Frequency of Recurrent Genetic Alterations.
    Argani P; Saoud C; Antonescu CR
    Genes Chromosomes Cancer; 2024 Sep; 63(9):e23268. PubMed ID: 39248552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apatinib treatment for KIT- and KDR-amplified angiosarcoma: a case report.
    Yang L; Liu L; Han B; Han W; Zhao M
    BMC Cancer; 2018 May; 18(1):618. PubMed ID: 29855279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cardiac angiosarcoma: case report and review of the literature.
    Kurian KC; Weisshaar D; Parekh H; Berry GJ; Reitz B
    Cardiovasc Pathol; 2006; 15(2):110-2. PubMed ID: 16533700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational landscape of primary breast angiosarcoma with repeated resection and recurrence over a 15-year period: A case report.
    Teruyama F; Kuno A; Murata Y; Nakagawa T; Shiba-Ishii A; Yuguchi S; Noguchi M
    Pathol Int; 2022 Sep; 72(9):457-463. PubMed ID: 35801418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. KDR activating mutations in human angiosarcomas are sensitive to specific kinase inhibitors.
    Antonescu CR; Yoshida A; Guo T; Chang NE; Zhang L; Agaram NP; Qin LX; Brennan MF; Singer S; Maki RG
    Cancer Res; 2009 Sep; 69(18):7175-9. PubMed ID: 19723655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary mammary angiosarcomas harbor frequent mutations in KDR and PIK3CA and show evidence of distinct pathogenesis.
    Beca F; Krings G; Chen YY; Hosfield EM; Vohra P; Sibley RK; Troxell ML; West RB; Allison KH; Bean GR
    Mod Pathol; 2020 Aug; 33(8):1518-1526. PubMed ID: 32123305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hemorrhagic nonspecific pericardial effusion as an initial symptom of angiosarcoma of the right heart].
    Fortmann T
    Z Kardiol; 2004 Oct; 93(10):807-12. PubMed ID: 15492896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational status of K-ras and TP53 genes in primary sarcomas of the heart.
    Garcia JM; Gonzalez R; Silva JM; Dominguez G; Vegazo IS; Gamallo C; Provencio M; España P; Bonilla F
    Br J Cancer; 2000 Mar; 82(6):1183-5. PubMed ID: 10735503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Malignant angiosarcoma of the right atrium in pregnancy. Diagnostic and therapeutic problems].
    Simon BC; Funck R; Drude L; Bohle RM; Reichart B; Maisch B
    Herz; 1994 Jun; 19(3):166-70. PubMed ID: 7927128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case report of two siblings. Cardiac angiosarcoma--rare tumor with non-specific symptoms and poor prognosis].
    Lundkvist L; Erntell H
    Lakartidningen; 2002 Oct; 99(42):4165-7. PubMed ID: 12448297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma.
    Megquier K; Turner-Maier J; Swofford R; Kim JH; Sarver AL; Wang C; Sakthikumar S; Johnson J; Koltookian M; Lewellen M; Scott MC; Schulte AJ; Borst L; Tonomura N; Alfoldi J; Painter C; Thomas R; Karlsson EK; Breen M; Modiano JF; Elvers I; Lindblad-Toh K
    Mol Cancer Res; 2019 Dec; 17(12):2410-2421. PubMed ID: 31570656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cardiac angiosarcoma: presenting with cardiac tamponade followed by cerebral hemorrhage with brain metastases.
    Ikeya E; Taguchi J; Yamaguchi M; Shibuya M; Kanabuchi K
    Jpn J Thorac Cardiovasc Surg; 2006 Dec; 54(12):528-31. PubMed ID: 17236655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma.
    Prenen H; Smeets D; Mazzone M; Lambrechts D; Sagaert X; Sciot R; Debiec-Rychter M
    Oncotarget; 2015 Nov; 6(34):36418-25. PubMed ID: 26474454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cardiac angiosarcoma with spontaneous ruptures of the right atrium and right coronary artery.
    Tang K; Shang QL; Zhou QC; Zhou JW; She XL; Zhang M
    Echocardiography; 2013 Jul; 30(6):E156-60. PubMed ID: 23488448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.